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During blastocyst implantation, interaction between integrins on the apical surface of the trophoblast and extracellular matrix (ECM) in
the endometrium anchors the embryo to the uterine wall. Strong adhesion of the blastocyst to fibronectin (FN) requires integrin signaling
initiated by exogenous fibronectin. However, it is not known how integrin signaling enhances blastocyst adhesion. We present new evidence
that the integrin, aIIbh3, plays a key role in trophoblast adhesion to fibronectin during mouse peri-implantation development. Trafficking of
aIIb to the apical surface of the trophoblast increased dramatically after blastocysts were exposed to fibronectin, whereas other fibronectin-
binding integrins, a5h1 and aVh3, were resident at the apical surface before ligand exposure. Functional comparisons among the three
integrins revealed that ligation of a5h1 most efficiently strengthened blastocyst fibronectin-binding activity, while subsequent trophoblast
cell migration was dependent primarily on the h3-class integrins. In vivo, aIIb was highly expressed by invasive trophoblast cells in the
ectoplacental cone and trophoblast giant cells of the parietal yolk sac. These data demonstrate that trafficking of aIIb regulates adhesion
between trophoblast cells and fibronectin as invasion of the endometrium commences.
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Introduction followed by apoptosis or retraction of the epithelial cellsIn the first week of mammalian development, the
blastocyst implants in the uterine wall and commences
placentation to establish a source of sustenance for
growth of the conceptus. The cellular events surrounding
interstitial implantation in rodents and humans include an
initial brief period of attachment between the apical
surfaces of trophoblast cells and the luminal epithelium,0012-1606/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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E-mail address: d.armant@wayne.edu (D.R. Armant).and trophoblast invasion of the underlying decidua (Car-
son et al., 2000; Schlafke and Enders, 1975). Trophoblast
adhesion during the invasive phase is based on integrin–
extracellular matrix (ECM) interactions. The endometrium
is rich in fibronectin (FN), laminin, collagens and other
ECM proteins (Leivo et al., 1980; Wartiovaara et al.,
1979; Wewer et al., 1985). Mouse embryos express
several integrins early during preimplantation develop-
ment (Schultz et al., 1997; Sutherland et al., 1993), and
ECM-mediated trophoblast adhesion and cell migration
require integrin activity (Armant et al., 1986a; Schultz
and Armant, 1995; Sutherland et al., 1988; Yelian et al.,
1993, 1995). However, mutant embryos lacking individ-
ual integrin alpha subunits all develop well beyond the
implantation stage (Hynes, 1996), suggesting that redun-
dancies of ligand specificity that occur among integrins
compensate for integrin loss at this stage of development.
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blast and ECM, it is necessary to resolve how integrin
function is regulated during blastocyst implantation. Mouse
trophoblast cells adhere to FN through the RGD integrin
recognition site in the central cell-binding domain of the
120-kDa proteolytic fragment, FN-120 (Yelian et al., 1995).
We have used mouse blastocyst explant cultures to examine
the ontogeny of FN-binding activity on the apical surface of
trophoblast cells, a hallmark of trophoblast differentiation to
the adhesion-competent stage. The apical surfaces of mural
trophoblast cells first acquire the ability to bind FN-120 on
gestation day (GD) 7 during blastocyst development in vitro
(Schultz and Armant, 1995). Experiments using a-amanitin
demonstrate that blastocyst differentiation to the adhesive
stage is dependent on gene expression that occurs on GD 3,
before blastocyst formation (Schultz et al., 1997). Thereaf-
ter, blastocysts differentiate normally in the presence of a-
amanitin, suggesting that post-transcriptional mechanisms
direct the acquisition of adhesion competence during peri-
implantation development.
Strong adhesion to FN requires that FN receptors are
available on the blastocyst surface, but this is not necessarily
sufficient. The integrin aVh3 appears on the apical surface
of trophoblast cells as early as GD 4 (Sutherland et al.,
1993), but fluorescent microspheres coated with FN-120
will not adhere to intact blastocysts until GD 7 (Schultz and
Armant, 1995). Trophoblast adhesion to FN, detected using
the bead binding approach, is developmentally regulated.
Treatment with bioactive molecules produced by the endo-
metrium specifically during peri-implantation development,
including heparin-binding EGF-like growth factor (Das et
al., 1994), calcitonin (Ding et al., 1994) and anandamide
(Schmid et al., 1997), accelerates in vitro blastocyst devel-
opment to near-in vivo rates (Wang et al., 1998, 1999,
2000). Disruption of the Golgi and vesicle trafficking to the
surface with brefeldin A on GD 6 delays the onset of
blastocyst adhesion, suggesting that the trophoblast devel-
opmental program is ultimately orchestrated through protein
trafficking (Schultz et al., 1997). Indeed, we have observed
that a5h1, another FN-binding integrin, translocates to the
apical plasma membrane of trophoblast cells on GD 7
(Schultz et al., 1997).
Although the timing of a5h1 translocation suggests that
FN-binding activity on GD 7 is dependent on this integrin,
blastocysts bind FN poorly until after they are exposed to
FN-120 for at least 1 h (Schultz and Armant, 1995),
suggesting that prior trafficking of aVh3 and a5h1 to the
trophoblast surface is required, but not sufficient for strong
adhesion to FN. Ligand-mediated upregulation of FN-bind-
ing activity is inhibited by brefeldin A, indicating a depen-
dence on additional protein trafficking (Schultz and Armant,
1995). Moreover, treatment with FN-120 initiates the trans-
location of intracellular vesicles that accumulate within
trophoblast cells (Wang et al., 2002). Competitive inhibition
of binding activity by soluble FN reveals no change in
receptor affinity (IC50) after exposure to FN-120, suggestingincreased receptor number as one possible mechanism
(Schultz and Armant, 1995). However, FN-120 engenders
no discernable change in the surface expression levels of
either aVh3 or a5h1 (Schultz et al., 1997). An attractive
hypothesis is that additional FN-binding integrins, or aux-
iliary proteins that modulate integrin binding activity, traf-
fick to the apical plasma membrane in response to FN
exposure.
We have observed during preimplantation develop-
ment expression of mRNA encoding the alpha subunit
of the integrin, aIIbh3 (Schultz et al., 1997), which
recognizes RGD sites within FN and several other
ligands (Hynes, 1992). A monoclonal antibody raised
against human aIIb labels mouse trophoblast cells out-
growing on FN (Yelian et al., 1995), suggesting a role
for this integrin in trophoblast adhesion and migration.
Although aIIbh3 is primarily recognized as a platelet-
associated integrin (Du et al., 1991) that has been
widely studied in cells of the megakaryocytic lineage
(Ginsberg et al., 1993; Phillips et al., 1988), its expres-
sion and function in invasive cancer cell lines has also
been demonstrated (Chen et al., 1997). We now present
evidence based on aIIb expression, cellular localization
and activity suggesting its participation in the ligand-
regulated strengthening of FN-binding activity on the
blastocyst surface and trophoblast cell migration on
immobilized FN. Additionally, we examine whether this
integrin operates coordinately with aVh3 and a5h1
during intracellular signaling and ligand interactions that
regulate trophoblast invasion of the endometrium.Materials and methods
Embryo and cell culture
Mouse oocytes and preimplantation embryos were pro-
duced and collected on embryonic day 0.5 (E0.5, where
E0.5 is the day following mating) through E3.5, as de-
scribed previously (Wang et al., 1998) using superovulated
females (strains NSA or MF-1, Harlan Sprague-Daly, Dub-
lin, VA) and B6SJL/J males (Jackson Laboratory, Bar
Harbor, ME). Implantation sites were obtained from natural
mating of CD-1 mice (Charles River Breeding Laboratories)
by their isolation from uteri at 0900 h on E5.5 or E6.5 5 min
after intravenous injection of a 1% Chicago Blue B solution
to locate embryos (Paria et al., 1993). Blastocysts collected
on E3.5 were cultured in Ham’s F10 medium (Life Tech-
nology, Inc., Gaithersburg, MD) containing antibiotics and 4
mg/ml BSA (Sigma Co., St. Louis, MO) as the only
additives. Since development does not progress at similar
rates in vivo and in vitro, the day blastocysts are harvested
and placed into culture is designated GD 4. B16-F10
melanoma cells (American Type Culture Collection, Par-
klawn Drive, Maryland, USA) were cultured, as described
by Yelian et al. (1995).
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area
FN-binding activity was assayed according to the method
of Schultz and Armant (1995) using mouse blastocysts
cultured to GD 7. FN-binding activity was upregulated by
exposing live blastocysts for 1 h at 37jC to 50 Ag/ml FN-
120 (Life Technology) in Ham’s F10 medium. The binding
assay was conducted at 4jC for 30 min with fluorescent-
green polystyrene microspheres (Bang’s Laboratories, Car-
mel, IN) coated with FN-120. Values obtained with embryos
after exposure to FN-120 were normalized after subtracting
the values obtained for embryos not exposed to FN-120.
Blastocysts cultured to GD 7 were transferred to micro-
drop cultures on Petri dishes coated overnight with 50 Ag/ml
human FN, mouse type-1 laminin (both from Life Technol-
ogy) or human fibrinogen (Calbiochem Corp., San Diego,
CA). The area occupied by outgrowing trophoblast cells
was determined using a computer-based image analysis
system (MCID M4, Imaging Research, St. Catherines,
Ontario, Canada), as described previously (Yelian et al.,
1993).
FN-binding activity and trophoblast outgrowth were
inhibited by including in the culture media monoclonal
antibodies (10 Ag/ml) against the extracellular domains of
mouse integrin subunits h1 (clone 9EG7, rat IgG2a), h3
(clone HMh3-1, hamster IgG), aIIb (clone MWReg30, rat
IgG1), a5 (clone 5H10-27, rat IgG2a) or aV (clone H9.2B8,
hamster IgG) (all from PharMingen, San Diego, CA).
Controls contained the appropriate nonimmune rat or ham-
ster IgG.
Immunofluorescence and confocal microscopy
Immunofluorescent labeling and confocal microscopy
were conducted, as previously described (Wang et al.,
2000). After paraformaldehyde fixation, blastocysts (GD
5, 6 and 7) or trophoblast outgrowths were permeabilized
for 15 min with 0.1% Triton X-100. Integrins were labeled
overnight at 4jC using site-directed, goat polyclonal anti-
bodies raised against the carboxy-terminal domains of the
aIIb (C-20), aV (Q-20) or a5 (C-19) integrin subunits (10
Ag/ml; Santa Cruz Biotechnology, Inc., Santa Cruz, CA).
Specificity of the aIIb antibody was demonstrated by
inclusion of the peptide antigen used for antibody produc-
tion (Santa Cruz Biotechnology, Inc.) with the primary
antibody solution. In some experiments, embryos were co-
labeled using a mouse monoclonal antibody against human
vinculin (1:400, Sigma Co.). Binding of primary antibody
was visualized using 10 Ag/ml Texas Red-conjugated,
affinity-purified, rabbit anti-goat IgG (Jackson Immunore-
search Laboratories, Inc., West Grove, PA). For double-
labeling experiments, embryos were incubated with 10 Ag/
ml each of FITC-conjugated donkey anti-mouse IgG and
Texas Red-conjugated donkey anti-goat IgG (Jackson
Immunoresearch Laboratories, Inc.). Nuclei were co-labeledby including 10 Ag/ml 4V,6-diamidino-2-phenylindole, HCl
(DAPI) in the secondary antibody mixture. Embryos were
incubated for 60 min at 37j in the secondary antibody
mixture, mounted on glass slides and viewed in a Zeiss
(Thornwood, NY) 310 confocal scanning laser microscope.
The relative surface labeling of aIIb was quantified in
confocal images using Simple PCI software (version 5.0;
Compix Inc., Cranberry Township, PA) to determine the
fluorescence intensity (mean grey level) of the surface
region circumscribed over each blastocyst (GD 7) exposed
(n = 12) or not exposed (n = 12) to FN-120.
Implantation sites dissected from pregnant mice on E5.5
or E6.5 were embedded in OCT and snap frozen in liquid
Histo-Freeze (Fisher, Chicago, IL). Frozen serial sections
(10 Am) were mounted onto glass slides, incubated 10 min
in acetone at 20jC, air dried and rehydrated in PBS.
Immunohistochemistry was conducted as described above
using the same goat antibody against aIIb and a rat
monoclonal antibody against cytokeratin 8 (TROMA-1;
1:200 hybridoma cell supernatant; Developmental Studies
Hybridoma Bank, Iowa City, IA), which is a trophoblast
marker (Brulet et al., 1980; Kemler et al., 1981). The
secondary antibody mixture contained 10 Ag/ml each of
FITC-labeled donkey anti-goat IgG, Texas Red-labeled
donkey anti-rat IgG and DAPI. Specimens were mounted
under cover slips using a ProLong Antifade Kit (Molecular
Probes, Eugene, OR) and viewed in a Leica (Wetzlar,
Germany) DM-IRB epifluorescence microscope. Images
were obtained using an ORCA digital camera (Hamamatsu
Photonics K.K., Hamamatsu City, Japan) and Simple PCI
(Compix) image processing software.
Western blotting
The specificity of the antibodies used to detect aIIb was
confirmed by Western blotting experiments using either
B16-F10 melanoma cells or platelets isolated from citrated
mouse blood (Bostwick et al., 1996). Approximately 10 Ag/
lane of protein from platelet or B16 cell extracts were
subjected to SDS gel electrophoresis (Laemmli, 1970)
without reducing agent and transferred to nitrocellulose
membranes. The membranes were blocked overnight at
room temperature with 5% powdered nonfat milk (Amer-
sham Pharmacia Biotech, Inc., Piscataway, NJ) in Tris-
buffered saline containing 0.1% Tween-20 (TTBS) and then
exposed for 1 h at 25jC to TTBS containing 5 Ag/ml rat
monoclonal antibody (PharMingen) or 0.4 Ag/ml goat
polyclonal antibody (Santa Cruz Biotechnology, Inc.)
against aIIb. Bound primary antibodies were detected using
either 3 Ag/ml biotin-SP-conjugated goat anti-rat IgG or 0.1
Ag/ml biotin-SP-conjugated rabbit anti-goat IgG (both from
Jackson Immunoresearch Laboratories, Inc.). The mem-
branes were washed with TTBS and then exposed for 30
min to peroxidase-conjugated streptavidin and followed
with ECL solution (Amersham Pharmacia Biotech, Inc.) to
visualize antibody-bound bands using Hyperfilm ECL
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markers (BioRad) and ECL molecular weight markers
(Sigma Co.) were electrophoresed in adjacent lanes.
Partial sequence of aIIb mRNA
B16-F10 melanoma cells and groups of 100 oocytes or
preimplantation embryos were subjected to total RNA iso-
lation and reverse transcription, as described previously
(Rout et al., 1997). A 701-bp segment of aIIb mRNA was
amplified from B16 melanoma cell total RNA by reverse
transcription and the polymerase chain reaction (RT-PCR)
using sense, antisense and nested primers, as described in
Schultz et al. (1997). RT-PCR products were visualized on
agarose gel (2%) under UV illumination after electrophoresis
(100 V) and ethidium bromide staining. The identified band
was excised from the gel, digested with agarase (USB
corporation, Cleveland, OH) and then cloned into a pCR II
vector (Invitrogen), according to the manufacturer’s instruc-
tions. The cDNA fragment was sequenced in both directions
by the Wayne State University core sequencing facility.
Sequence information was compared with nucleic acid and
amino acid sequence data available on the World Wide Web
using the BLAST sequence alignment algorithm (Altschul et
al., 1990). This RT-PCR cloning strategy for aIIb was also
used to clone a 701-bp cDNA from mouse blastocysts.
Relative abundance RT-PCR
A primer set derived from the blastocyst 701-bp aIIb
cDNA sequence (Schultz et al., 1997) was used for direct
RT-PCR amplification of aIIb mRNA to generate a single
358-bp band on agarose gels. PCR was conducted in 50 Al of
50 mM Tris–HCl (pH 9.5), 2.5 mM MgCl2, 15 mM
ammonium persulfate, 0.5 U Taq polymerase (Life Tech-
nologies), 0.2 mM each of dATP, dCTP, dGTP and dTTP,
and 1 AM each of the sense and antisense oligonucleotide
primers. The PCR reaction was initiated with a hot start at
95jC for 1 min, followed by 40 thermal cycles at 95jC for
30 s, 62jC for 30 s and 72jC for 1 min. A final extension
for 7 min was conducted at 72jC. The PCR reaction was
terminated by lowering the temperature to 4jC. The RT-
PCR product was cloned into a PCR II vector and se-
quenced in both directions to confirm its identity.
A quantitative estimate of the relative abundance of
specific mRNAs during embryonic development was
obtained, as reported previously (Wang et al., 1998). Oocyte
and embryo extracts prepared for estimation of relative
mRNA abundance were supplemented during total RNA
isolation with 0.125 pg/embryo of exogenous rabbit a-
globin mRNA (Sigma Co.). To ensure that genomic DNA
contamination was eliminated, h-actin cDNAwas amplified
from each sample using the published method (De Sousa et
al., 1993). The relative abundance of a-globin, glyceralde-
hyde 3-phosphate dehydrogenase (GAPDH) and aIIb
mRNA was determined by the method of Temeles et al.(1994) after 25, 32 and 25 thermal cycles, respectively. The
PCR conditions and primer sequences used for amplification
of GAPDH and a-globin cDNAs were identical to published
reports (Daston et al., 1996; Temeles et al., 1994). An
amount of cDNA equivalent to 0.4 mouse oocytes or
embryos was amplified in 50 Al PCR reaction mixture
containing 1 ACi of [a-32P]-dCTP (6000 Ci/mmol, Amer-
sham Pharmacia Biotech, Inc.). The incorporation of radio-
active dCTP into the amplicon was determined by agarose
(2%) electrophoresis of 10 Al of PCR product mixed with
unlabeled PCR product that had been amplified in a separate
reaction for 40 cycles. A band of the expected size was
visualized by ethidium bromide staining, excised from the
gel using a razor blade and subjected to scintillation count-
ing. The incorporation of radioactive dCTP into the RT-PCR
product of a-globin message was used to normalize the
radioactivity of GAPDH and aIIb reaction products from
corresponding samples. Normalization compensates for
intersample variations in the efficiency of RNA isolation
and RT.
Statistical analysis
All experiments subjected to statistical analysis were
repeated at least three times. Differences in the relative
amounts of GAPDH and aIIb mRNA were tested for
significance (P < 0.05) using a Student’s t test. FN-binding
activity values were obtained using at least 15 blastocysts,
and percentage of outgrowth values were based on a
minimum of 90 blastocysts. Differences in FN-binding
activity and outgrowth area between treatment groups were
tested for significance using an ANOVA with the Bonfer-
roni–Dunn post hoc test. The fluorescence intensity of
labeled aIIb on the surface of blastocysts was compared
using a two-tailed Mann–Whitney U test since the data
were nonuniformly distributed.Results
Expression of aIIb mRNA during preimplantation
development
A 701-bp fragment of aIIb cDNA (AF045019) was
cloned from mouse blastocysts using a nested PCR method
(Chen et al., 1992) that produced a similar amplicon from
mouse B16 melanoma cells (Fig. 1A, lanes 1 and 2). The
sequence demonstrated a high degree of similarity to the aIIb
nucleotide sequence derived from human platelets (79%;
X06831) and the complete mouse mRNA sequence (99%;
AF170316). The sequence corresponded to nucleotides
2398–3097 of the mouse aIIb mRNA (Thornton and Poncz,
1999), and the derived amino acid sequence included five
residues of the cytoplasmic domain, the entire transmem-
brane domain and 200 residues of the adjacent extracellular
domain, including the proteolytic cleavage site.
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tocyst aIIb sequence, the expression of aIIb mRNA was
confirmed in mouse blastocysts by RT-PCR. RT-PCR reac-
tions for h-actin, a-globin, aIIb and GAPDH all produced
single amplicon bands of the expected sizes (Fig. 1A, lanes
3–6). According to the published mouse sequence of Thorn-
ton and Poncz (1999), our aIIb primers should span threeintrons (24–26) and would generate a 1229-bp PCR product
from genomic DNA. Therefore, the production of a single
358-bp aIIb amplicon (Fig. 1A, lane 3) could have only
occurred with cDNA that was not contaminated with ge-
nomic DNA. Consistent with that finding, h-actin was
amplified by RT-PCR using primers that span an intron, but
only produced the 243-bp amplicon expected from cDNA. In
agreement with our previous report (Schultz et al., 1997),
these data demonstrate that mouse blastocysts expressed
authentic aIIb mRNA.
Relative abundance of aIIb mRNAwas estimated during
preimplantation development (Fig. 1B) using 25 thermal
cycles, based on preliminary experiments showing that the
incorporation of radioactive deoxynucleotide into the ampli-
con was linear between 23 and 35 thermal cycles (Fig. 1B
inset). RT-PCR reactions for GAPDH and exogenously
added a-globin were conducted as previously detailed
(Wang et al., 1998). Estimates of the relative abundance
of aIIb mRNA revealed an increase between the 2-cell and
the 16-cell morula stages, while GAPDH mRNA levels
remained relatively unchanged (Fig. 1B). By the blastocyst
stage (E3.5), aIIb levels decreased. Closer examination of
aIIb mRNA levels during transition from the 8-cell to
blastocyst stages (Fig. 1C) revealed a 5-fold increase that
occurred primarily during the initial 12-h period as the
morula formed and underwent cavitation. Transcriptional
activity during the period of cavitation is critical for the
onset of adhesion competence at the late blastocyst stage
(Schultz et al., 1997). Accordingly, embryos cultured with 1
Ag/ml a-amanitin from 8 to 14 h after collection of 8-cell
embryos expressed reduced levels of aIIb mRNA at 24
h (1.73 F 0.161), as compared with untreated embryos
(5.09 F 0.607). We conclude that transcription-dependent
accumulation of aIIb mRNA occurs in cavitating morulae atFig. 1. Integrin subunit aIIb mRNA expression during preimplantation
development. (A) PCR (40 cycles) amplification products of reverse-
transcribed mRNA were electrophoresed on agarose gels next to 100-bp
ladders (L; sizes in bp are indicated to the right). A 701-bp fragment was
produced from mouse B16 cell or blastocyst RNA (lanes 1 and 2,
respectively) using primers based on the rat aIIb sequence. Sequencing
showed the band to be aIIb cDNA and that the minor 300-bp product was
not. Primers based on the derived mouse aIIb sequence were used to
amplify a 358-bp product from blastocyst cDNA (lane 3). Exogenously
added mRNA for a-globin was amplified from the same cDNA preparation
(lane 4; 257 bp). Blastocyst cDNAwas also used to amplify h-actin (lane 5;
243 bp) and GAPDH (lane 6; 350 bp). (B) The relative abundance of aIIb
(circles) and GAPDH (squares) mRNA were determined by RT-PCR, as
detailed in Materials and methods, in unfertilized oocytes (E), zygotes (Z),
2-cell embryos (2C), late morula stage embryos that had begun to cavitate
(M) and fully developed blastocysts (B). The radioactivity incorporated into
aIIb or GAPDH amplicons was normalized to that generated from
exogenously added a-globin mRNA. All amplification reactions were
conducted within the linear range, which was determined as shown for aIIb
mRNA in the inset. (C) The relative abundance of aIIb and GAPDH
mRNA was assessed as in B for 8-cell embryos during their culture for
80 h to the mid-blastocyst stage. Duplicate samples are shown in B, and
the mean F SEM of three to four replicate experiments appear in C.
*P < 0.05, compared to GAPDH.
Fig. 2. Specificity of antibodies against aIIb. Mouse platelet proteins were
separated by nonreducing SDS gel electrophoresis, as detailed in Materials
and methods, and Western blotted using polyclonal (PCAb) or monoclonal
(MCAb) antibodies against aIIb. The migration of molecular weight
standards is indicated next to each lane in kDa.
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Developmental regulation of aIIb and other
RGD-recognizing integrins
We have studied aIIb protein expression and function
using two antibodies; a polyclonal antibody that was raised
against a peptide corresponding to the carboxy-terminal
cytoplasmic domain of aIIb and a monoclonal function-
blocking antibody MWReg30 that recognizes the extracel-
lular domain of aIIb. Western blotting of mouse platelet
extracts demonstrated that both antibodies recognize single
proteins of a similar size (Fig. 2). The antibodies appear to
recognize aIIb, based on the estimated Mr (approximately
135 kDa) of the bands on nonreducing SDS gels (Smyth et
al., 2000). In preliminary immunofluorescence labeling
experiments, the polyclonal antibody against aIIb specifi-
cally labeled human WM 983B melanoma cells transfected
with aIIb cDNA, but not mock transfected cells (Supple-
mentary data, Fig. I), as previously reported using different
antibodies (Trikha et al., 2002).
The polyclonal antibody was used to localize aIIb in
developing mouse blastocysts cultured on plates coated with
FN-120 to induce trophoblast outgrowth. Nonimmune IgG
did not label any cells and labeling with the antibody against
aIIb was inhibited in a dose-dependent manner by addition
of the peptide antigen used to generate the antibody (Sup-
plementary data, Fig. II), demonstrating its specificity. A
BLAST search of the NCBI protein database with this
sequence returned no proteins other than aIIb. In agreement
with an earlier investigation of mouse blastocyst outgrowth
that utilized a monoclonal antibody raised against human
aIIb (Yelian et al., 1995), the protein appeared in migratory
trophoblast cells within structures resembling focal adhe-
sions that were co-labeled with an antibody against vinculin
(Fig. 3). Focal adhesions containing aIIb were prominent
along the outer edge of migrating trophoblast cells (Figs. 3D
and E, arrows). The aIIb subunit also appeared within focal
adhesions throughout spreading cells. Proteins labeled by
the antibodies were resistant to extraction of adherent
trophoblast cells with 0.5% Triton X-100 (Supplementary
data, Fig. III), indicating the association of aIIb with both
the FN-coated substratum and the detergent-resistant cyto-
skeleton at focal adhesions.
Monoclonal antibodies recognizing the extracellular
domains of aVh3 and a5h1 have been used to localize
these integrins on the apical surface of the trophoblast
during blastocyst differentiation to an adhesion-competentFig. 3. Integrin subunit aIIb protein expression in outgrowing trophoblast cells. T
were viewed by confocal microscopy after double staining with goat anti-aIIb Ig
detailed in Materials and methods. Images were captured in 1-Am optical sections o
the green and red images shows areas labeled with both antibodies, which appear y
e are shown in panels D and E, respectively. Arrows indicate regions labeled bystage (Schultz et al., 1997). While aVh3 emerges on the
apical surface early during development, a5h1 is not
apical surface-localized until GD 7. Confocal microscopy
was used to localize aIIb subunits in permeabilized mouse
blastocysts with the polyclonal antibody utilized in Fig. 3,
and to similarly localize the other integrins using poly-
clonal antibodies against the carboxyl-termini of a5 and
aV (Fig. 4). As expected, aV was detected at the apical
surface of trophoblast cells from GD 5 onward, while a5
did not accumulate at the apical surface until GD 7 (arrow
heads in Figs. 4A and H). The apical surface expression of
neither alpha subunit noticeably increased after blastocysts
were exposed to soluble FN-120 for 1 h (Figs. 4J and K),
which increases FN-binding activity (Schultz and Armant,
1995). After FN exposure, there appeared to be depletion
of a5 from other cellular locations, suggestive of an effect
on a5 trafficking. Localization of aIIb revealed very little
expression on the apical surface of the trophoblast from
GD 5 through GD 7. However, after exposure to FN-120
on GD 7, aIIb staining was clearly observed along the
apical surface of trophoblast cells (Fig. 4L, arrow head).
Image analysis was used to estimate the relative surface
labeling of aIIb, revealing a 2.5-fold increase (P = 0.004)
in surface localization of aIIb after treatment with FN-120.
This remarkable accumulation of aIIb in the apical domain
of the trophoblast plasma membrane is the first report of a
protein trafficking event in conjunction with the upregula-
tion of blastocyst FN-binding activity and suggests thatrophoblast cells outgrowing from blastocysts cultured for 24 h on FN-120
G (A; shown in red) and mouse anti-vinculin IgG (C; shown in green), as
btained at the lower cell surface. A merged image (B) created by combining
ellow. Higher-magnification images of the boxed regions in B labeled d and
both antibodies that appear to be focal adhesions.
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Fig. 4. Expression of FN-binding integrin subunits during blastocyst differentiation. Blastocysts cultured in the absence of ECM were fixed on GD 5–7 or on
GD 7 after a 1-h exposure to 50 Ag/ml FN-120, and stained with antibodies against aV, a5 or aIIb, as indicated. Texas Red-labeled integrins appear red and
DAPI-labeled nuclei are blue. Arrowheads indicate sites of surface-localized integrin subunit at earliest time after trafficking to the apical domain of the plasma
membrane. Images (1-Am optical sections) were obtained by confocal microscopy.
U.K. Rout et al. / Developmental Biology 268 (2004) 135–151142this event may be required for trophoblast outgrowth in
vitro and implantation in utero.
In support of a critical role for aIIbh3 in blastocyst
adhesion to FN, we observed that high-affinity FN-binding
activity was inhibited in a dose-dependent manner by themonoclonal antibody MWReg30 that recognizes the extra-
cellular domain of aIIb (Fig. 5). MWReg30 is a function-
blocking antibody capable of disrupting aIIbh3-mediated
aggregation of mouse platelets (Nieswandt et al., 1999). A
residual 25% of the binding activity resisted inhibition by
Fig. 5. Inhibition of FN-binding activity by anti-aIIb antibody. Blastocysts
cultured to GD 7 were exposed to 50 Ag/ml FN-120 for 1 h and assayed for
FN-binding activity, as detailed in Materials and methods, in the presence
of 0–20 Ag/ml of monoclonal antibody MWReg30 against aIIb (circles) or
20 Ag/ml nonimmune rat IgG (triangle). Mean (F SEM) FN-binding
activities are shown for at least 15 embryos assayed in three separate
experiments.
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Nonimmune mouse IgG was without effect at 20 Ag/ml. We
have previously reported similar inhibition with antibodies
against aV, h3, a5 or h1 (Schultz and Armant, 1995). It
appears that adhesion to FN requires each of the FN-binding
integrins, aIIbh3, aVh3 and a5h1, which all recognize the
RGD sequence in FN-120.
Integrin aIIb localization in implantation sites
Because the aIIb subunit is translocated to the apical
surface of the trophoblast in the adhesion-competent blasto-
cysts, we envisioned the involvement of aIIbh3 in tropho-
blast adhesion to the endometrium during the early stages of
blastocyst implantation. Therefore, the cell-specific expres-
sion of aIIb was examined in utero by immunofluorescence
in serial frozen sections of mouse implantation sites. The aIIb
subunit was expressed by uterine epithelium, but not in the
decidua (data not shown). At the beginning of the invasive
phase of implantation on E5.5, aIIb was expressed at high
levels in primary trophoblast cells populating the parietal
yolk sac and adhering to Reichert’s membrane (Fig. 6B,
arrow). At this stage, the ectoplacental cone was not labeled.
Decidua distal to the implantation site was not labeled by
antibody against aIIb (Supplementary data, Fig. IV), while
decidua immediately adjacent to the trophoblast was slightly
above background fluorescence. Cytokeratin 8 (TROMA-1antibody), a marker for trophectoderm and embryonic endo-
derm lineages (Brulet et al., 1980; Kemler et al., 1981), co-
localized with aIIb in trophoblast giant cells of the parietal
yolk sac (Fig. 6C). TROMA-1 also appeared throughout the
ectoplacental cone and extraembryonic ectoderm. On E6.5,
aIIb was expressed in trophoblast giant cells residing adja-
cent to the Reichert’s membrane, as well as in secondary
trophoblast cells in the outer region of the ectoplacental cone
(Fig. 6E, arrows). TROMA-1 co-localized with aIIb in those
locations, although the Reichert’s membrane appeared to be
labeled only by antibody against aIIb (Figs. 6G and H).
Parietal endoderm (pe, Figs. 6D and G) and extraembryonic
ectoderm (x), as well as trophoblast stem cells in the central
core of the ectoplacental cone, were stained only by
TROMA-1 (Fig. 6F), while the intraembryonic region (e)
was always negative for both TROMA-1 and aIIb. Levels of
aIIb increased between the proximal ( p) and distal (d)
regions of the ectoplacental cone (Fig. 6I), as did the size of
trophoblast giant nuclei (Fig. 6J). The localization of aIIb
suggested its involvement in trophoblast adhesion to the
endometrium, as well as a role in trophoblast invasion of
the decidua.
Synergistic regulation of trophoblast outgrowth by integrins
The coordinate trafficking of aV, a5 and aIIb during
blastocyst development, aIIb localization in focal adhesions
formed by trophoblast cells migrating on FN and the
expression of aIIb in both primary and secondary giant
trophoblast cells at implantation sites indicated that both
adhesion and migration of the trophoblast could be regula-
ted by RGD-binding integrins. Therefore, we examined the
respective roles of a5h1, aVh3 and aIIbh3 during adhesion
and migration of primary trophoblast cells migrating on FN-
120. Blastocysts cultured to GD 7 were transferred to plates
coated with ECM proteins and cultured in the presence or
absence of inhibitory monoclonal antibodies raised against
the extracellular domains of mouse integrin subunits. None
of the antibodies completely prevented trophoblast cell
adhesion or outgrowth; however, inhibitory effects could
be discerned by measuring cell migration after 24 h of
culture. Embryos cultured in medium supplemented with
nonimmune IgG, anti-a5 IgG or anti-h1 IgG produced
trophoblast outgrowths with areas comparable to controls;
however, outgrowth areas were significantly reduced by
monoclonal antibodies against aIIb, aV or h3 (Fig. 7A,
solid bars). Outgrowth on laminin, which is independent of
aIIbh3 or other RGD-recognizing integrins, was unaffected
by the MWReg30 antibody against aIIb (Fig. 7A, open
bars), demonstrating the specificity of inhibition by that
antibody during outgrowth on FN-120.
We examined the cellular organization of these integrins
and their disruption by anti-aIIb antibody during blastocyst
outgrowth. Immunocytochemistry and confocal microscopy
were used to co-localize aIIbh3, aVh3 or a5h1 with the
focal adhesion protein, vinculin, at the substratum surface of
Fig. 6. Expression of aIIb during implantation in utero. Frozen sections of E5.5 (A–C) and E6.5 (D–J) mouse implantation sites were labeled with DAPI
(blue), antibody C-20 against aIIb (green) and monoclonal antibody TROMA-1 (red), as described in Materials and methods. A merged composite of E and F
indicates the spatial relationships of the aIIb and TROMA-1 labeling patterns (G). Images at higher magnification are shown in the upper right corner of the
figure. Strong anti-aIIb labeling of the Reichert’s membrane was detected in the region bordering the trophoblast and parietal endoderm (H). Labeling with
anti-aIIb (I) and DAPI (J) is illustrated in a section spanning the proximal ( p) to distal (d) regions of the ectoplacental cone, as indicated by the arrow. pe,
parietal endoderm; tb, trophoblast; e, intraembryonic region; x, extraembryonic ectoderm.
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were observed for each integrin (Fig. 8). Of the three alpha
subunits, aIIb most closely paralleled vinculin in its distri-
bution, accumulating in focal adhesions at the margin of
migrating trophoblast cells. The aV subunit could be found
throughout the adherent plasma membrane and was prom-
inent in some, but not all, focal adhesions, while a5 was not
highly expressed and was largely absent from the leading
edge of migrating cells. Inhibition of trophoblast outgrowth
by the MWReg30 antibody altered trophoblast morphology
by reducing cell spreading and increasing the production of
narrow protrusions. Large vinculin-labeled focal adhesions
became prominent centrally beneath cells, but were largely
absent at cell margins. All three alpha subunits were highly
associated with the vinculin-labeled structures. Disruption
of aIIb appeared to result in a general redistribution and
reorganization of focal adhesion and integrins within tro-
phoblast cells, suggesting the coordinate regulation of these
integrins.Using the trophoblast outgrowth model, we comparative-
ly examined the role of a5h1 with the h3 integrins. Since
fibrinogen is recognized by aVh3 and aIIbh3, but not by
a5h1 (Hynes, 1992), trophoblast adhesion and migration on
it is independent of a5h1. Outgrowth on fibrinogen was less
robust than on FN-120, resulting in smaller outgrowth areas
after 24 h of culture (compare control values in Figs. 7A and
B). Antibodies against a5 or h1 did not reduce the size of
outgrowths on fibrinogen after 24 h of culture (Fig. 7B), as
expected. However, significant inhibition of outgrowth
expansion was obtained with antibodies against aVor aIIb,
IIb, and nearly complete inhibition was observed by either
combining anti-aV and anti-aIIb (av + aIIb) or using anti-
h3 (Fig. 7B). Based on these results, we conclude that
trophoblast migration was highly dependent on h3-class
integrins. The reduced outgrowth on fibrinogen compared to
FN-120, however, suggests that interactions with a5h1
positively contribute to the process of trophoblast out-
growth.
Fig. 7. Inhibition of FN-binding integrins during trophoblast outgrowth. Blastocysts were cultured to GD 7 and then transferred to plates coated with FN-120
(solid bars), laminin (open bars) or fibrinogen (hatched bars). In A and B, outgrowth culture was conducted using medium supplemented with BSA only (Con),
10 Ag/ml nonimmune IgG or 10 Ag/ml of monoclonal antibodies against the extracellular domains of a5 (a5), aIIb (aIIb), aV (av), h1 (b1) or h3 (b3). The bar
in B labeled av + aIIb indicates treatment with 10 Ag/ml each of antibodies against aIIb and aV. In C, outgrowth culture was conducted in nonsupplemented
medium after exposure for 1 h to 0 Ag/ml (Con) or 50 Ag/ml of fibrinogen (Fg) or FN-120 (FN). The area of outgrowing trophoblast was determined after
culture for 24 h (A and B) or 8 h (C), as described in Materials and methods. For reference, the dashed horizontal lines indicate the average area of intact
blastocysts before commencement of outgrowth. Mean (F SEM) outgrowth areas are shown for at least 15 embryos assayed in three separate experiments.
*P < 0.05, compared to control group for corresponding substrate.
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The ability of FN-120 to produce larger blastocyst out-
growths than fibrinogen suggested that interactions with
a5h1 may accelerate the developmental program initiating
trophoblast adhesion and, thus, hasten the commencement
of outgrowth. After only 8 h of culture, trophoblast out-
growths on FN-120 were already quite large, while tropho-
blast cells on fibrinogen were just beginning to migrate,
producing areas that were not much larger than the size of
intact blastocysts (Fig. 7C). To activate a5h1, embryos were
exposed to soluble FN-120 for 1 h, an experimental manip-
ulation known to upregulate integrin-mediated FN-binding
activity (Schultz and Armant, 1995). Afterwards, the em-
bryos were washed several times to remove FN-120 and
transferred to a new plate coated with fibrinogen. Embryos
treated with FN-120 rapidly commenced trophoblast cell
migration on fibrinogen to produce outgrowths within 8 h
that were as large as those of embryos cultured on FN-120,while embryos similarly treated with soluble fibrinogen
generated outgrowths that were not significantly larger than
those of nontreated embryos on fibrinogen (Fig. 7C). Our
findings suggest that ligation of a5h1 with FN-120 rapidly
initiates trophoblast adhesive activity early during out-
growth culture. Indeed, attainment of strong adhesion to
FN, as determined using the FN-binding assay, required a 3-
h exposure to soluble fibrinogen, whereas FN-120 upregu-
lated FN binding activity in 1 h (Fig. 9). This finding
implicates a primary role for a5h1 in early signaling events
that establish trophoblast adhesion to FN and initiate inva-
sive activities. Apparently, signaling by aVh3 and aIIbh3
can also upregulate adhesion, but does so less efficiently.
Trophoblast cell migration depends primarily on b3-class
integrins
Reduction of trophoblast outgrowth area by antibodies
that disrupt aVh3 or aIIbh3, but not those that disrupt
Fig. 8. Localization of integrin alpha subunits in migrating trophoblast and perturbation by anti-aIIb antibody. Blastocysts cultured to GD 7 were further
cultured on FN-120-coated plates for 12 h in nonsupplemented medium (Control) or medium supplemented with inhibitory monoclonal antibody against aIIb
(aIIb Inhibited). The embryos were then double labeled with antibodies against the indicated integrin subunits (red) and vinculin (green). Trophoblast cells at
the margin of the outgrowths are shown in 1-Am optical sections obtained at the adherent (lower) cell surface.
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important role in trophoblast cell motility. To explore this
idea further, we examined the effect of integrin availability
on both the initiation rate and area of trophoblast outgrowth
(Fig. 10). Outgrowth on FN-120 (involving all three integ-
rins) was compared to outgrowth on fibrinogen (involvingonly aVh3 and aIIbh3) and outgrowth on FN-120 in
medium containing antibody against h3 (involving only
a5h1). On fibrinogen, the commencement of outgrowth
began approximately 1 h after the start of outgrowth on FN-
120 (Fig. 10A). Although late in starting, embryos cultured
on fibrinogen produced large outgrowths with areas not
Fig. 9. Rate of activation of FN-binding activity by FN-120 and fibrinogen.
Blastocysts cultured to GD 7 were exposed to 50 Ag/ml FN-120 (A, open
circles) or fibrinogen (B, solid circles) for the indicated time and assayed
for FN-binding activity, as in Fig. 5. Mean (F SEM) FN-binding activities
are shown for at least 15 embryos assayed in three separate experiments.
Data were normalized against the peak values obtained for FN-120 (at 60
min) or fibrinogen (at 180 min), respectively, which were similar in
absolute value.
Fig. 10. Rate of outgrowth initiation and trophoblast cell migration
mediated by h1- or h3-class integrins. Outgrowth culture was conducted, as
in Fig. 7, using blastocysts cultured to GD 7. Blastocyst were cultured on
plates coated with FN-120 (solid squares, solid bars), fibrinogen (open
triangles, hatched bars) or FN-120 in medium containing 10 Ag/ml of
monoclonal antibody against h3 (open squares, open bars). The percentage
of embryos commencing trophoblast outgrowth was determined during the
first 6 h (A) and the area of outgrowth was determined after 12–48 h (B), as
in Fig. 7. Cumulative percentages for at least 45 embryos pooled from three
separate experiments are shown in A. Mean (F SEM) outgrowth areas for
the same embryos are shown in B. *P < 0.05, compared to time-matched
embryos cultured on FN-120.
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10B). We conclude that, in the absence of a5h1, trophoblast
cells retain their motility, but the onset of adhesion is
delayed. This hypothesis is supported by the relative effi-
ciencies of FN-120 and fibrinogen in upregulating adhesion
to FN-120 (Fig. 9). It is also apparent that in the absence of
aVh3 or aIIbh3 activity cell migration is greatly compro-
mised. This is indicated by the reduced trophoblast migra-tion when h3-class integrins are disrupted, which
significantly reduced the area of migration (Fig. 10B). The
poor motility of trophoblast cells exposed to anti-h3 mono-
clonal antibody made it difficult to detect any migrating
cells during the first 6 h of culture on FN-120 (Fig. 10A,
open squares), although all embryos in all treatment groups
were positively scored by 12 h. Our results suggest that
trophoblast outgrowth is not solely dependent on any one
integrin and that both h1- and h3-class integrins perform
important functions during FN-mediated adhesion and cell
migration.
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We have presented new evidence suggesting a novel role
for the integrin aIIbh3 during mouse peri-implantation
development. Ligand-induced adhesion to FN at the apical
surface of the trophoblast was associated with aIIb mobili-
zation to the apical plasma membrane domain and was
inhibited by a function-blocking antibody against aIIb.
Trafficking of aIIb could constitute a critical molecular
event during blastocyst implantation that advances tropho-
blast adhesion to the endometrium. Expression of aIIb
protein within implantation sites was initially elevated in
trophoblast giant cells derived from the primary trophoblast,
and later increased in migratory secondary trophoblast cells
in the distal region of the ectoplacental cone. These findings
suggest that aIIb may help anchor the embryo in the uterine
wall and mediate tight adhesion to the Reichert’s membrane,
as well as provide adhesive activity required for cell motility
during invasion of the endometrium. In vitro analysis of
trophoblast outgrowths indicated that aIIbh3 operates in
concert with other FN-binding integrins, a5h1 and aVh3.
While the h3-class integrins appeared to be the most critical
receptors for cell migration, our data suggest that a5h1 is
particularly effective in transducing intracellular signals that
initiate strong adhesion to FN.
Role for aIIbb3 in regulating blastocyst adhesion to FN at
implantation
Expression of aIIb mRNA becomes elevated during
cavitation, a period of development previously found to be
crucial for transcription of genes required for FN-binding
activity at the late blastocyst stage (Schultz et al., 1997) and
trophoblast outgrowth (Schindler and Sherman, 1981). After
blastocyst formation, aIIb mRNA expression returned to
low levels, based on a semiquantitative assay. There was
little accumulation of aIIb mRNA in embryos exposed to a-
amanitin during cavitation, confirming that it is among the
transcripts inhibited in the previous studies (Schindler and
Sherman, 1981; Schultz et al., 1997) of transcriptional
requirements for trophoblast adhesion. Therefore, aIIb
mRNA is expressed during a period of development when
genes mediating trophoblast adhesion to FN are transcribed.
The critical phase of transcription is followed by an
extended period of translation, processing and trafficking
required for trophoblast adhesion to FN (Schultz et al.,
1997). In light of our previous findings that ligand-mediated
upregulation of FN-binding activity is inhibited by brefeldin
A (Schultz and Armant, 1995) and associated with the
apparent exocytosis of intracellular vesicles observed in
trophoblast cells by transmission electron microscopy
(Wang et al., 2002), it is noteworthy that aIIb trafficks to
the apical surface of the primary trophoblast once the
blastocyst contacts FN. A semiquantitative estimate of
aIIb trafficking established that its accumulation on the
embryo surface increased significantly as blastocysts en-counter FN. Immunocytochemistry at the ultrastructural
level will be required to determine whether aIIb subunits
are mobilized from an intracellular pool or from the baso-
lateral surface of the trophoblast. We suggest that aIIb
trafficking could be a critical event initiated by integrin
signaling that strengthens FN-binding activity as the tro-
phoblast transforms from a transporting epithelium to
invasive cells. Indeed, the aIIb-specific MWReg30 anti-
body effectively inhibited FN-binding activity, demonstrat-
ing a functional requirement for aIIbh3. While adhesion to
FN is orchestrated during preimplantation development
through sequential insertion of aVh3 and a5h1 into the
apical plasma membrane (Schultz et al., 1997), these new
data indicate that strong adhesion does not develop until
reserves of aIIb accumulate at the trophoblast surface.
The integrin aIIbh3 is uniquely positioned during tro-
phoblast differentiation to modulate adhesion within the
apical plasma membrane in response to ECM components,
including FN. Evidence supporting a role for aIIb in
mediating trophoblast adhesion in utero was provided by
its localization on E5.5 in giant cells of the parietal yolk sac
that are derived from the primary trophoblast. On E6.5, high
levels of aIIb were produced in trophoblast cells adhering to
the Reichert’s membrane, as well as those penetrating the
decidua surrounding the parietal yolk sac and ectoplacental
cone. The trophoblast marker, TROMA-1, was co-localized
with aIIb. The evident staining of aIIb in the Reichert’s
membrane, itself, suggested that the ECM was infused with
integrin-laden cellular extensions from adhering trophoblast
giant cells.
Trophoblast adhesion and outgrowth from blastocysts
cultured on FN or laminin is indistinguishable (Armant et
al., 1986b). The major laminin receptor, a7h1, conforms to a
cell-specific pattern of expression during implantation similar
to that of aIIb (Klaffky et al., 2001), suggesting that tropho-
blast adhesion to laminin and FN is coordinately regulated.
Unlike a7, aIIb was not expressed in trophoblast stem cell
populations of the extraembryonic ectoderm and innermost
ectoplacental cone. Indeed, there was an obvious gradient of
aIIb expression within the ectoplacental cone that increased
in the more distal regions populated by cells with large nuclei
(Figs. 6I and J). This expression pattern could reflect the
upregulation of aIIb by invasive giant trophoblast cells. The
unique aspects of aIIb and a7 expression suggest functional
differences in trophoblast interactions with FN and laminin
that are not readily discernable from trophoblast behavior
during in vitro culture.
Cooperative activities of b1 and b3 integrins during
trophoblast adhesion and migration
We have presented experimental evidence suggesting
that RGD-binding integrins of the h1 and h3 classes
contribute cooperatively to trophoblast adhesion and migra-
tion on FN. Inhibitory studies of trophoblast migration
suggested that although each integrin could support some
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required participation by all three receptors. Moreover, there
was almost no trophoblast outgrowth when the contributions
of all three RGD-binding integrins were abolished by
culturing on fibrinogen (eliminates a5h1) in the presence
of antibody against h3 (eliminates aVh3 and aIIbh3). The
greater sensitivity of h3 integrins to antibody inhibition of
cell migration is consistent with their extensive distribution
in adhesion complexes of migrating trophoblast cells during
outgrowth. An important distinction was the accumulation
of aV and aIIb, but not a5, in association with vinculin at
cell margins where motile cells would be expected to
strengthen their adhesion to the substratum (Sheetz et al.,
1998). In the presence of the aIIb antibody, all three
integrins became organized into vinculin-associated struc-
tures located centrally under the cell body and absent from
cell margins. Cells exhibiting this pattern of focal adhesions
tend to be nonmigratory (Sheetz et al., 1998). Indeed, we
observed that the antibody reduced cell spreading.
Although the role of a5h1 in trophoblast cell motility
appears to be relatively minor considering its limited ex-
pression in migrating cells, it is not without influence on
blastocyst outgrowth. Trophoblast migration was reduced
when blastocysts were cultured on fibrinogen, a substratum
that is unrecognized by a5h1. Closer inspection revealed
that trophoblast cells migrated well on fibrinogen after the
initial 24 h, but commencement of outgrowth was delayed.
Retardation of outgrowth correlated with slower activation
of FN-binding integrins on the surface of GD 7 blastocysts
by fibrinogen, compared to FN-120. Upregulation of FN-
binding activity is the result of integrin-mediated signaling
initiated by exposure to FN-120 (Wang et al., 2002). Anti-
bodies against a5 or h1 failed to inhibit outgrowth, perhaps
because the antibodies induce integrin signaling through
a5h1. Poor binding of FN by trophoblast cells before a5h1
trafficking to the apical plasma membrane domain (Schultz
et al., 1997) may reflect a requirement for a5h1 to effi-
ciently transduce intracellular signals. It appears that all
three FN-binding integrins can ultimately mediate tropho-
blast motility and are capable of transducing ‘‘outside-in’’
signals to strengthen adhesion when FN is initially con-
tacted. However, the participation of all three integrins may
engender optimal trophoblast invasion during implantation,
as no one integrin is more proficient than the others in all
required functions.
Functional redundancies and complementation among the
RGD-recognizing integrins
The ability of trophoblast cells to adhere to FN in the
presence of function-blocking antibodies seems contradicted
by the ability of antibodies recognizing each integrin to
inhibit FN-binding activity (Schultz and Armant, 1995). It
should be noted that the FN-binding assay is conducted at
4jC, which may impede compensation by alternate integ-
rins. However, blastocysts treated with blocking antibodiesduring outgrowth culture at 37jC would be able to mobilize
alternate integrins with similar function. The three integrins
examined here each bind to the RGD recognition site in the
central cell-binding domain of FN (Hynes, 1992), which is
perhaps why they are at least somewhat complimentary. Our
data support the view that trophoblast cells commit to a
developmental program dependent on several FN-binding
integrins, but are able to alter that program when the activity
or expression of an integrin is eliminated.
Our experimental results indicate important roles for
a5h1, aVh3 and aIIbh3 in trophoblast adhesion to FN,
although null mutations of these genes do not produce any
obvious implantation or trophoblast deficiencies (De Arcan-
gelis and Georges-Labouesse, 2000; Hynes, 1996). Both the
a5 and aV genes have been ablated in mice without altering
implantation (Bader et al., 1998; Yang et al., 1993). Humans
with the hereditary hemorrhagic disorder Glanzmann throm-
basthenia survive and reproduce with disruptive mutations of
either aIIb or h3 (Newman et al., 1991). Elimination of
either gene in mice fails to obstruct the establishment of
pregnancy (Hodivala-Dilke et al., 1999; Tronik-Le et al.,
2000), indicating that implantation and gestation are possible
in the absence of aIIbh3. Deletion of the h1 subunit results
in developmental arrest shortly after implantation, although
h1-deficient primary trophoblast cells can spread and mi-
grate on FN (Fassler and Meyer, 1995; Stephens et al., 1995).
Compensation in integrin-deficient, mutant embryos could
be achieved through the expression of alternate FN-binding
integrins, including a8h1, avh5, avh6 and avh8, which
have not been studied in preimplantation mouse embryos. It
is also possible that trophoblast cells lacking FN-binding
integrins can implant by adhering to ECM proteins other
than FN, since they migrate equally well in vitro on laminin,
entactin and a variety of collagens (Armant et al., 1986b;
Carson et al., 1988; Yelian et al., 1993).
Our findings shed new light on the respective functions
of three FN-binding integrins during trophoblast differenti-
ation, demonstrating that they operate cooperatively to
transduce signals that initiate adhesion and to directly
mediate adhesion and cell migration on ECM containing
FN. It is well established that integrins are capable of
activating or inhibiting one another through intracellular
signaling and crosstalk (Schwartz and Ginsberg, 2002).
Crosstalk, rather than their respective binding interactions
with FN, may account for the interrelationships of integrins
during blastocyst implantation. Binding assays and immu-
nocytochemical analysis of blastocysts exposed to FN-120
suggest that aIIbh3 is recruited to the apical surface of
trophoblast cells to achieve strong FN-binding activity. The
expression of aIIb within the implantation site contrasted
with relatively low levels of aV and a5 (data not shown),
suggesting that aIIbh3 is prominent in mediating adhesive
interactions between trophoblast giant cells and components
of the decidual ECM in vivo. aIIbh3 is expressed in tumor
cell lines of diverse histological origin and appears to play a
critical role in tumor cell invasion (Chang et al., 1992; Chen
U.K. Rout et al. / Developmental Biology 268 (2004) 135–151150et al., 1997; Trikha et al., 2002; Wojtukiewicz et al., 1993),
which is consistent with its function in invasive trophoblast
cells. The proficiency with which aIIbh3 receives and
generates intracellular signals (Parise, 1999) and the need
to dynamically modulate integrin-mediated adhesion during
cell motility (Holly et al., 2000) suggests that trophoblast
function during implantation is greatly enhanced by aIIbh3
expression. It is now clear in platelets, certain invasive
tumors and the trophoblast that aIIbh3 activation by extra-
cellular agonists provides an adhesion system that is highly
responsive to the cell’s surroundings and may constitute a
strategy to modulate cellular adhesion and invasion that is
more ubiquitous than previously suspected.Acknowledgments
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